Guardado en:
| Autor principal: | |
|---|---|
| Formato: | Artículo científico |
| Lenguaje: | en |
| Publicado: |
Universidad del Valle
2013
|
| Materias: | |
| Acceso en línea: | https://www.redalyc.org/articulo.oa?id=28327007009 https://www.redalyc.org/journal/283/28327007009/ https://www.redalyc.org/journal/283/28327007009/html/ https://www.redalyc.org/journal/283/28327007009/28327007009.epub https://www.redalyc.org/journal/283/28327007009/movil |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Tabla de Contenidos:
- Albendazole-induced liver injury: a case report David Ríos Juan C Restrepo Medicina Hepatitis albendazole druginduced liver injury (DILI) We report a case of a 47-year-old male, who was referred to the clinical hepatology services at Pa-blo Tobón Uribe Hospital for evaluation of a jaundice syndrome. After undergoing several exams, we diagnosed hepatic hydatidosis and the patient was treated with albendazole; however, after five months of uninterrupted treatment the patient again consulted and his liver test showed marked hepatocellular damage. This time, the patient was diagnosed with drug-induced liver injury due to albendazole, based on information from the clinical record, history of drug consumption, clinical and laboratory tests improved after discontinuing the medication and after discarding other possible causes; this diagnosis was supported by the CIOMS/RUCAM scale, which showed a “likely” correlation between hepatocellular damage and drug toxicity etiology. 2013 artículo científico 0120-8322 https://www.redalyc.org/articulo.oa?id=28327007009 https://www.redalyc.org/journal/283/28327007009/ https://www.redalyc.org/journal/283/28327007009/html/ https://www.redalyc.org/journal/283/28327007009/28327007009.epub https://www.redalyc.org/journal/283/28327007009/movil en http://www.redalyc.org/revista.oa?id=283 Colombia Médica application/pdf Universidad del Valle Colombia Médica (Colombia) Num.2 Vol.44